Form 4 for STE Steris
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-01 · accession 0001628280-25-044117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-01 | STE | Madsen Julia | SVP, GM, Life Sciences | F - Tax | $0.00 | -52 | 10.7K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-10-01 | F | D | 52 | $0.00 | 10,710 | D | — | — | (F1) 52 shares were withheld from the 144 restricted shares that vested on October 1, 2025. These 52 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 144 ordinary shares were awarded to Ms. Madsen on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. (F2) As of October 1, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |